David M. Faleck MD
Inflammatory Bowel Disease
Attending Gastroenterologist
Request appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Faleck
Dr. David Faleck is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Albert Einstein College of Medicine and has been in practice 14 years. He is one of 36 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Gastroenterology. He has more than 50 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2015 - 2018
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2012 - 2015
Albert Einstein College of MedicineClass of 2012
University of PennsylvaniaBA, Biology, Jewish Studies, summa cum laude, 2004 - 2008
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2022 - 2027
CT State Medical License 2024 - 2026
NY State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Member AOA, 2012
- Member Phi Beta Kappa, 2007
Clinical Trials
- Stool Transplant to Control Treatment-related Diarrhea Start of enrollment: 2021 May 10
Publications & Presentations
PubMed
- Brief Report: Intestinal Lymphangiectasia With Selpercatinib and Pralsetinib Treatment.Jaime Rubio-Perez, Sameh Daher, Sabrina T Lin, Clare Wilhelm, Ling Feng Ye
Journal of Thoracic Oncology. 2026-08-01 - Upadacitinib Achieved Rapid Response in Biologic-Refractory Immune Checkpoint Inhibitor-Related Enterocolitis.David M Faleck, Jonathan V Lo, Patrick T Magahis, Michael A Postow, Rachel E Niec
Clinical Gastroenterology and Hepatology. 2026-05-26 - Office-based flexible sigmoidoscopy allows rapid assessment and management of suspected immune checkpoint inhibitor-related colitis.Alana Siev, Pamela Livingstone, Erika Tom, Tara Corso, Isabel Preeshagul
Annals of Gastroenterology. 2025-06-25
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
